1. Monocyte-derived DC maturation strategies and related pathways: a transcriptional view

   • Luciano Castiello
   • Marianna Sabatino
   • David F. Stroncek

   Review 22 January 2011 Pages: 457 - 466

   

2. Ipilimumab experience in heavily pretreated patients with melanoma in an expanded access program at the University Hospital of Siena (Italy)

   • Anna Maria Di Giacomo
   • Riccardo Danielli
   • Michele Maio

   Original Article 18 December 2010 Pages: 467 - 477

   

3. Gc protein-derived macrophage-activating factor (GcMAF) stimulates cAMP formation in human mononuclear cells and inhibits angiogenesis in chick embryo chorionallantoic membrane assay

   • Stefania Pacini
   • Gabriele Morucci
   • Marco Ruggiero

   Original article 14 December 2010 Pages: 479 - 485

   

4. Survival after intratumoral interleukin-2 treatment of 72 melanoma patients and response upon the first chemotherapy during follow-up

   • Benjamin Weide
   • Thomas Kurt Eigentler
   • Claus Garbe

   Original article 21 December 2010 Pages: 487 - 493

   

5. Mechanisms of T-cell protection from death by IRX-2: a new immunotherapeutic

   • Malgorzata Czystowska
   • Miroslaw J. Szczepanski
   • Theresa L. Whiteside

   Original article 23 December 2010 Pages: 495 - 506

   

6. Physical and biological properties of homophilic therapeutic antibodies

   • Ann Jay Bryan
   • Heinz Kohler

   Original article 28 December 2010 Pages: 507 - 514

   

7. A peptidoglycan monomer with the glutamine to serine change and basic peptides bind in silico to TLR-2 (403–455)

   • Yufeng Li
   • Clay L. Efferson
   • Constantin G. Ioannides

   Original article 28 December 2010 Pages: 515 - 524

   

8. Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes

   • Michael S. Leibowitz
   • Pedro A. Andrade Filho
   • Robert L. Ferris

   Original Article 05 January 2011 Pages: 525 - 535

   

9. NFAT1 transcription factor is central in the regulation of tissue microenvironment for tumor metastasis

   • Miriam B. F. Werneck
   • Adriana Vieira-de-Abreu
   • João P. B. Viola

   Original Article 12 January 2011 Pages: 537 - 546

   

10. Targeting NKT cells and PD-L1 pathway results in augmented anti-tumor responses in a melanoma model

    • Kevin Durgan
    • Mohamed Ali
    • Yvette E. Latchman

    Original Article 15 January 2011 Pages: 547 - 558

    

11. Reduced tumorigenesis of EG7 after interleukin-10 gene transfer and enhanced efficacy in combination with intratumorally injection of adenovirus-mediated lymphotactin and the underlying mechanism

    • Jianbin Zhang
    • Zhidong Zhou
    • Dajing Xia

    Original article 15 January 2011 Pages: 559 - 573

    

12. Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cells

    • Emilie P. Buddingh
    • Marco W. Schilham
    • Arjan C. Lankester

    Original Article Open access 15 January 2011 Pages: 575 - 586

    

13. Quantitative assessment of MLAA-34 expression in diagnosis and prognosis of acute monocytic leukemia

    • Jianqiang Zhao
    • Aili He
    • Liufang Gu

    Original Article 15 January 2011 Pages: 587 - 597

    

14. Immunocompetent cell functions in Ph⁺ acute lymphoblastic leukemia patients on prolonged Imatinib maintenance treatment

    • Roberta Maggio
    • Nadia Peragine
    • Robin Foà

    Original Article 15 January 2011 Pages: 599 - 607